Savient Pharmaceuticals Inc (NASDAQ:SVNT)
CAPS Rating:
A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.
A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.
Recs
Stock has run up a little BUT profitability is not on the horizon